ARTICLE | Clinical News
Calgene regulatory update
October 4, 1993 7:00 AM UTC
Roger Salquist, president and CEO of CGNE, told attendees at the Montgomery Securities Twenty-Third Annual Investment Conference that CGNE is expecting FDA approval of its genetically engineered tomat...